.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Managing diabetic macular edema (DME) remains a complex challenge for clinicians across India. While anti-vascular endothelial growth factor (anti-VEGF) therapy is the standard of care, treatment response varies significantly among patients. Consequently, the integration of AI in DME treatment offers a promising shift from generalized protocols to personalized precision medicine. These advanced tools help clinicians navigate the high treatment burden and individualize risk stratification.
Artificial intelligence systems leverage deep learning to identify subtle imaging biomarkers that the human eye might miss. These models analyze multimodal data, including fundus images and follow-up optical coherence tomography (OCT). By capturing statistical associations, AI can accurately classify likely responders before initiating therapy. Furthermore, these tools quantify imaging biomarkers to track disease progression over time. Therefore, clinicians can better predict central subfield thickness and vision outcomes after the initial loading doses.
AI-driven decision support also streamlines clinical workflow by integrating systemic data with local ocular findings. This comprehensive approach allows for tailored \"treat-and-extend\" intervals, reducing the cumulative treatment burden for patients. For example, systems may recommend switching to steroids or combination strategies when a poor response is predicted early. However, the medical community must still address issues like generalizability and ethical deployment. Despite these hurdles, AI-enabled support is becoming an essential component of modern ophthalmology.
AI analyzes OCT images and clinical data to identify patterns associated with treatment response. This allows doctors to choose between different anti-VEGF agents or alternative therapies more effectively based on individual risk profiles.
Yes, advanced machine learning models can estimate the likely frequency of injections by evaluating baseline imaging and the initial response to loading doses, helping manage patient expectations and clinical resources.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult with a qualified specialist regarding medical conditions. Refer to the latest local and national guidelines for clinical practice.
References
Ratra D et al. The evolving role of artificial intelligence in optimizing treatment and patient selection in diabetic macular edema. Indian J Ophthalmol. 2026 May 01. doi: 10.4103/IJO.IJO_3152_25. PMID: 42060353.
Chakroborty S, Gupta M, Devishamani CS, et al. Narrative review of artificial intelligence in diabetic macular edema: Diagnosis and predicting treatment response using optical coherence tomography. Indian J Ophthalmol. 2021 Nov;69(11):2999-3008.
Luvisi J et al. AI Model May Predict Anti-VEGF Treatment Response in Diabetic Macular Edema. American Academy of Ophthalmology (AAO). Published March 20, 2025.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Explore how AI models optimize diabetic macular edema (DME) treatment by predicting anti-VEGF response and individualizing patient selection....
4 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
